Relevant risk for women with BRCA1 and BRCA2 mutations

ANZ Journal of Surgery

Volumn 77, Issue 5, 2007, Pages 309-

  Furnival, Colin ^a  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

BREAST CANCER; BREAST EXAMINATION; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER PREVENTION; CANCER REGISTRY; CANCER RISK; CANCER SCREENING; CARCINOGENESIS; ECHOGRAPHY; EDITORIAL; GENE MUTATION; HETEROZYGOTE; HUMAN; MAMMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; ONCOGENE; OVARY CANCER; RISK ASSESSMENT;

BREAST NEOPLASMS; FEMALE; GENES, BRCA1; GENES, BRCA2; HETEROZYGOTE; HUMANS; MIDDLE AGED; MUTATION; OVARIAN NEOPLASMS;

EID: 34248143446     PISSN: 14451433     EISSN: 14452197     Source Type: Journal    
DOI: 10.1111/j.1445-2197.2007.04109.x     Document Type: Editorial

References (4)

1. Chen S, Iversen ES, Friebel T et al. Characterization of BRCA1 and BRCA2 mutations in a large United States sample. J. Clin. Oncol. 2006 24 : 863 71.
2. Hopper J, Southey M, Dite G et al. Population-based estimate of the average age-specific cumulative risk of breast cancer for a defined set of protein - truncating mutations in BRCA1 and BRCA2: Australian Breast Cancer Family Study. Cancer Epidemiol. Biomarkers Prev. 1999 8 : 741 47.
3. Suthers GK. Cancer risks for Australian women with a BRCA1 or a BRCA2 mutation. ANZ J. Surg. 2007 77 : 314 19.
4. Hadden WE. Recommendations for the surveillance of young women at increased risk for breast cancer. Aust. Radiol. 2007 51 : 1 11.